Abbott | ABT - Loan Capital


Abbott reported $29.64B in Loan Capital for its fiscal quarter ending in March of 2026.





Loan Capital Change Date
Abbott USD 29.64B 19.74B Mar/2026
Agilent USD 3.64B 594M Jun/2026
AtriCure USD 61M 0 Jun/2026
Baxter International USD 8.62B 6M Jun/2026
Becton, Dickinson and Co. USD 13.51B 1.2B Jun/2026
Bio-Rad Laboratories USD 803M 100K Jun/2026
Boston Scientific USD 10.86B 148M Mar/2026
Cooper Companies USD 1.86B 17.7M Mar/2026
Danaher USD 25.15B 7.59B Jun/2026
Dexcom USD 1.3B 200K Jun/2026
Edwards Lifesciences USD 598.7M 1.3M Jun/2026
Globus Medical USD 398K 38K Mar/2026
Insulet USD 929.5M 0 Jun/2026
Integra LifeSciences USD 1.83B 2.05M Jun/2026
Intuitive Surgical USD 0 0 Mar/2025
J&J USD 37.34B 183M Jun/2026
Medtronic USD 26.12B 1.76B Mar/2026
Merit Medical Systems USD 736.26M 1.1M Jun/2026
Pfizer USD 60.5B 70M Jun/2026
Smith & Nephew USD 3.21B 85M Jun/2026
Solventum Corp USD 4.57B 2M Jun/2026
Stryker USD 14.19B 32M Jun/2026
Tandem Diabetes Care USD 602.58M 809K Jun/2026
Teleflex USD 2.72B 206.24M Jun/2026
Terumo JPY 209.52B 109.61B Jun/2026
Thermo Fisher Scientific USD 39.18B 890M Jun/2026
Zimmer Biomet Holdings USD 6.28B 17.6M Jun/2026